(Q58010774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

diffuse large B-cell lymphoma

1 reference

inferred from title

author

Santiago Montes-Moreno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Esperanza Martin-Sanchez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Margarita Sanchez-Beato

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Miguel A. Piris

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

Ken H Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

9

Manuela Mollejo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

8

Raquel Pajares

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

Lina Odqvist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

7

Lydia Sánchez-Verde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

6

Laura Cereceda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

11

Francisco Mazorra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Roxana E Sánchez-Pacheco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Manuel F Fresno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Carmen Ruíz-Marcellán

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

7 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1331-1337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Genetic heterogeneity of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Oncogenically active MYD88 mutations in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Regulation and function of NF-kappaB transcription factors in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB–inducing kinase while activating both canonical and alternative nuclear factor-κB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Circuitry of nuclear factor kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Prostate stem cell antigen is overexpressed in prostate cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

Prognostic impact of C-REL expression in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

7 January 2021

inferred from DOI database lookup

Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

7 January 2021

inferred from DOI database lookup

MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.34

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/MODPATHOL.2014.34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24603590%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference